Dobutamine Hydrochloride

Thông số

49745-95-1Số CAS

256-464-1Số EC

4-[2-[4-(4-hydroxyphenyl)butan-2-ylamino]ethyl]benzene-1,2-diol;hydrochlorideTên IUPAC

C18H24ClNO3Công thức hóa học

337.8 g/molKhối lượng phân tử

Dobutamine hydrochloride; 49745-95-1; Dobutamine Hcl; DL-Dobutamine hydrochloride; 0WR771DJXV; NSC-299583; Dobutamine hydrochloride in dextrose 5%; DTXSID30964383; NSC299583; Dobutamine hydrochloride in dextrose 5% in plastic container; CHEBI:4671; Dobutamine in Dextrose; RefChem:56521; Hydrochloride, Dobutamine; DTXCID801392084; Dobutamine Hydrochloride In Dextrose; 4-(2-((1RS)-3-(4-Hydroxyphenyl)-1-methylpropylamino)ethyl)benzene-1,2-diol monohydrochloride; Dobutrex; Inotrex; 52663-81-7; Dobutamine (hydrochloride); C18H24ClNO3; 4-(2-((4-(4-hydroxyphenyl)butan-2-yl)amino)ethyl)benzene-1,2-diol hydrochloride; rac Dobutamine Hydrochloride; MFCD00153795; 1,2-Benzenediol, 4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]ethyl]-, hydrochloride (1:1); 4-[2-[4-(4-hydroxyphenyl)butan-2-ylamino]ethyl]benzene-1,2-diol;hydrochloride; (+-)-4-(2-((3-(p-Hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatechol hydrochloride; SMR000058435; Dobutamina clorhidrato [Spanish]; SR-01000075265; EINECS 256-464-1; UNII-0WR771DJXV; NSC 299583; Inofrex; LY 46236; Posiject; 49745-95-1 (HCl); Dobutrex;; 1,2-Benzenediol, 4-(2-((3-(4-hydroxyphenyl)-1-methylpropyl)amino)ethyl)-, hydrochloride; 1,2-Benzenediol, 4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]ethyl]-, hydrochloride; 4-(2-{[4-(4-hydroxyphenyl)butan-2-yl]amino}ethyl)benzene-1,2-diol hydrochloride; S-1000; Dobutrex (TN); 1,2-BENZENEDIOL, 4-(2-((3-(4-HYDROXYPHENYL)-1-METHYLPROPYL)AMINO)ETHYL)-, HYDROCHLORIDE (1:1); Prestwick_741; 1,2-Benzenediol, 4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]ethyl]-; Dobutamine hydrochloride [USAN:USP:BAN:JAN]; Dobutamine hydrochloride CRS; SCHEMBL41609; 1,2-Benzenediol, 4-(2-((3-(4-hydroxyphenyl)-1-methylpropyl)amino)ethyl)-, hydrochloride, (+-)-; MLS000860012; MLS001332503; MLS001332504; MLS002222253; REGID_for_CID_65324; orb1299176; CHEMBL1200418; SCHEMBL30094854; Dobutamine hydrochloride, >=98%; HMS1569G05; MSK10203; Tox21_500365; DOBUTAMINE HYDROCHLORIDE [MI]; EBC-77132; HY-15746R; Dobutamine hydrochloride (JP18/USP); DOBUTAMINE HYDROCHLORIDE [JAN]; AKOS015907731; Dobutamine (hydrochloride) (Standard); CCG-220352; CCG-221669; Dobutamine HCL;Dobutamine Hydrochloride; DOBUTAMINE HYDROCHLORIDE [USAN]; FH27507; KS-1050; LP00365; (+/-)-3,4-Dihydroxy-N-[3-(4-hydroxyphenyl)-1-methylpropyl]-beta-phenethylamine hydrochloride; (.+-.)-4-[2-[[3-(p-Hydroxyphenyl)-1-methylpropyl]amino]ethyl]pyrocatechol hydrochloride; 4-(2-((3-(p-Hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatecholhydrochloride; 4-[2-[[3-(4-Hydroxyphenyl)-1-methylpropyl]amino]ethyl]-1,2-benzenediol hydrochloride; DOBUTAMINE HYDROCHLORIDE [MART.]; DOBUTAMINE HYDROCHLORIDE [WHO-DD]; NCGC00093799-01; NCGC00093799-02; NCGC00261050-01; AC-11653; HY-15746; LY-46236; DB-051684; D4335; EU-0100365; NS00089557; T8149; DOBUTAMINE HYDROCHLORIDE [EP IMPURITY]; DOBUTAMINE HYDROCHLORIDE [ORANGE BOOK]; D 0676; D00632; DOBUTAMINE HYDROCHLORIDE [EP MONOGRAPH]; DOBUTAMINE HYDROCHLORIDE [USP IMPURITY]; DOBUTAMINE HYDROCHLORIDE [USP MONOGRAPH]; F240166; SR-01000075265-1; SR-01000075265-3; SR-01000075265-6; Q27106435; Dobutamine hydrochloride, British Pharmacopoeia (BP) Reference Standard; Dobutamine hydrochloride, European Pharmacopoeia (EP) Reference Standard; 1, 4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]ethyl]-, hydrochloride, (.+-.)-; 3,4-Dihydroxy-N-[3-(4-hydroxyphenyl)-1-methylpropyl]-beta-phenethylamine Hydrochloride; Dobutamine hydrochloride, United States Pharmacopeia (USP) Reference Standard; ( inverted question mark)-4-[2-[[3-(4-Hydroxyphenyl)-1-methylpropyl]amino]ethyl]-1,2-benzenediol hydrochloride; (+/-)-4-(2-((3-(P-HYDROXYPHENYL)-1-METHYLPROPYL)AMINO)ETHYL)PYROCATECHOL HYDROCHLORIDE; 1,2-BENZENEDIOL, 4-(2-((3-(4-HYDROXYPHENYL)-1-METHYLPROPYL)AMINO)ETHYL)-, HYDROCHLORIDE, (+/-)-; 4-(2-{[4-(4-Hydroxyphenyl)butan-2-yl]amino}ethyl)benzene-1,2-diol--hydrogen chloride (1/1)Tên gọi khác